TCT 24: The INFINITY-SWEDEHEART Trial
TCT Conference 2024 - Significant reduction in TLF and TVF and flattening of event curves after 6 months in favour of DynamX Bioadaptor.
Dr David Erlinge (Skane University Hospital, Lund, SE) joins us onsite at TCT Conference to discuss the findings from INFINITY-SWEDEHEART (NCT04562805).
INFINITY-SWEDEHEART is a prospective, multicenter, randomized registry-based clinical trial, where patients with complex lesion subsets were randomized 1:1 to receive either the DynamX Bioadaptor (Elixir Medical Corporation) or the Resolute Onyx (Medtronic) drug-eluting stent. 2400 patients in Sweden were enrolled in the trial, and were followed-up by phone at 30 days and 1 year, and by clinical and diagnostic registries at 6 months and 2 to 5 years. The primary outcome measure was target lesion failure (TLF) at one year.
Findings showed low and non-inferior TLF rates at 12 months, and significant reduction in TLF and TVF, with a flattening of event curves after 6 months. There was a substantial clinical benefit for high-risk subgroups including acute coronary syndrome after 6 months, and consistent effect across those prespecified subgroups.
Interview Questions:
1. What's the reasoning behind trial?
2. What was the study design and the patient population?
3. What were your key findings?
4. What are the take-home messages for practice?
5. What further study is needed?
Recorded at TCT Conference in Washington, 2024.
Editor: Jordan Rance
Video Specialist: Dan Brent and Oliver Miles
Support: This is an independent interview produced by Radcliffe Cardiology.
Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: / radcliffecardiology
Follow us on X: https://x.com/radcliffeCARDIO
Смотрите видео TCT 24: The INFINITY-SWEDEHEART Trial онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь Radcliffe Cardiology 31 Октябрь 2024, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 14 раз и оно понравилось людям.